Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage
US10729767B2 · kind B2 · utility
5Cited by
25References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2016 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Sep 10, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides humanized anti-C1s antibodies. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the humanized anti-C1s antibodies; and host cells comprising the nucleic acids. The present disclosure provides compositions comprising the humanized anti-C1s antibodies. The present disclosure provides methods of use of the humanized anti-C1s antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.